How do we tackle the conflict between intellectual property and the drive towards open science?

Open access and open science have become hot topics in the worlds of research and academic publishing, with the drive towards open science enabling better collaboration, alongside greater accessibility and inclusion. But are there downsides to this, and is there a tension between making science open and protecting intellectual property? In this session we will discuss the challenges in this space, and how we might overcome them.

Submit your questions and comments to the panellists now.

Panellists
Pam Hill, Senior Director, Head of Open Innovation Programme, AstraZeneca Pharmaceuticals

Anne-Marie Conn, European and Chartered UK Patent Attorney at Abel & Imray

Alex Reip, Chief Technology Officer at Oxford NanoSystems  

Professor Mike Waring, Professor of Medicinal Chemistry, Newcastle University